Press Release

Digital Salutem Welcomes Gil Bashe and Stacy Hurt as Board Members

DATE OF RELEASE: WEDNESDAY, OCT 20, 2021 8:59 AM GMT

LONDON, UK, – Digital Salutem is delighted to announce that the digital health influencers, Gil Bashe and Stacy Hurt, have joined Digital Salutem’s team as board members.

Digital Salutem is a digital health company on a mission to make Healthcare uncomplicated. They have been a part of the digital health revolution since its inception and remain determined to contribute to the ways in which Healthcare is accessed and delivered.

Stacy Hurt
Gil Bashe

The new board members offered a few of their thoughts on the issues of accessible health and patient-focused care

“Innovation is only meaningful when people can apply it and address their health needs.  Digital health is the bridge that ensures people with medical and wellness priorities are part of the decision-making conversation.”

Gil Bashe, Global Health Chair, FINN Partners

Gil currently Chairs Global Health at FINN Partners. As a C-suite leader, he sees communications as the bridge to connect healers with those seeking to be healed. A digital health leader, author, and keynote speaker, Gil’s career includes emergency care delivery, public affairs, public relations, and crisis management.

“As a chronic illness patient and full-time caregiver managing numerous doctors’ appointments and tests, I am seeking any way to make my ‘healthcare life’ easier.  The key to this is technology.  Innovations in digital health can help reduce the burden of coordinating care as well as improve outcomes through meeting patients where we are.”

Stacy Hurt, MHA, MBA, Advocate / Speaker / Consultant

HIMSS Digital Influencer. Stacy is an award-winning healthcare executive turned caregiver for her intellectually and developmentally disabled son and she is a stage IV colorectal cancer survivor.  She now serves as a global patient advocate and works as a consultant and keynote speaker to represent patients as stakeholders in clinical decision making, healthcare technology user experience, and pharma/biotech drug development.

João Bocas, CEO of Digital Salutem and a recognized Keynote Speaker and Influencer in the healthcare and wearables market, expressed his delight at the news in an accompanying statement.

“We’re absolutely delighted to have Gil Bashe and Stacy Hurt join Digital Salutem as board members. Both are highly successful in their chosen sectors of healthcare, with extensive experience in the digital health arena. They will play an important role in helping us achieve our goals and mission, to meaningfully impact society, people, and humanity through the use of technology. Gil and Stacy are extremely committed to contributing to Digital Health worldwide, their contributions, endeavors, and missions aligning closely to our work and company ethos. We are looking forward to our future collaboration and making a meaningful impact on the industry ”

To learn how Digital Salutem can empower your company’s digital healthcare transformation, organizational growth, or brand positioning contact us to arrange for an in-depth discussion on your needs and ambitions. You can reach us via our website, via phone: +44 (0) 203 36204 or via e-mail: info@digitalsalutem.com

Digital Salutem

Queen Mary University Enterprise Zone,
The QMB Innovation Centre,
5 Walden Street,
London,
E1 2EF,
United Kingdom

Medika Life

Medika Life is a digital Health Publication for both the medical profession and the public. Make informed decisions about your health and stay up to date with the latest developments and technological advances in the fields of medicine.

Recent Posts

Death Is Not A Failure

In my conversation with Dr. Elaine Chen of Rush University Medical Center, who is both…

14 hours ago

Executive action may actually drive up medicines prices

*This story will be updated as more details become available* President Trump’s executive order could…

3 days ago

Trump’s Drug Price Gambit: Cheaper for America, But Who Pays the Price?

Donald Trump is back at it, making big waves in the world of pharmaceuticals. On…

3 days ago

Cancer Isn’t Random: What 42% of Diagnoses Have in Common — and How You Can Lower Your Risk.

“The fault, dear Brutus, is not in our stars, but in ourselves…”— William Shakespeare, Julius Caesar.…

2 weeks ago

When Is Exercise Not Exercise, and Is That Good Enough?

Going for walks, dancing, and doing housework —although not technically exercises —any kind of movement counts toward your…

2 weeks ago

How Real-World Evidence Proves the Power of Patient Engagement

Data isn’t just an asset—it’s a trust marker. In life sciences, our credibility hinges on…

3 weeks ago

This website uses cookies. Your continued use of the site is subject to the acceptance of these cookies. Please refer to our Privacy Policy for more information.

Read More